208 related articles for article (PubMed ID: 12905952)
1. [Chromosomal analysis, fluorescence in situ hybridization method, and spectral karyotyping in hematologic malignancies].
Nara N
Rinsho Byori; 2003 Jun; Suppl 126():124-30. PubMed ID: 12905952
[No Abstract] [Full Text] [Related]
2. [Novel diagnostic procedures for hematologic malignancies on the basis of genomic alterations].
Taniwaki M
Rinsho Ketsueki; 2001 May; 42(5):352-5. PubMed ID: 11452449
[No Abstract] [Full Text] [Related]
3. [Molecular diagnostic tests in hematologic diseases].
Tohda S; Nara N
Rinsho Byori; 2001 Mar; 49(3):205-9. PubMed ID: 11307316
[TBL] [Abstract][Full Text] [Related]
4. Multicolor FISH.
Jalal SM; Law ME
Methods Mol Biol; 2002; 204():105-20. PubMed ID: 12397793
[No Abstract] [Full Text] [Related]
5. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
[TBL] [Abstract][Full Text] [Related]
6. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
Lee DY; Cho HI; Kang YH; Yun SS; Park SY; Lee YS; Kim Y; Lee DS
Cancer Genet Cytogenet; 2004 Jul; 152(1):1-7. PubMed ID: 15193435
[TBL] [Abstract][Full Text] [Related]
7. High-resolution copy number array in the molecular cytogenetic diagnostics of pediatric malignant hematological disorders.
Wikhager C; Ögärd I; Martinsson T; Abrahamsson J; Palmqvist L; Sjögren H
Oncol Rep; 2012 May; 27(5):1429-34. PubMed ID: 22344473
[TBL] [Abstract][Full Text] [Related]
8. Detection of immunoglobulin heavy chain gene rearrangements in hematologic malignancies.
Gleissner B; Thiel E
Expert Rev Mol Diagn; 2001 Jul; 1(2):191-200. PubMed ID: 11901814
[TBL] [Abstract][Full Text] [Related]
9. Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization.
Nebral K; König M; Schmidt HH; Lutz D; Sperr WR; Kalwak K; Brugger S; Dworzak MN; Haas OA; Strehl S
Haematologica; 2005 Jun; 90(6):746-52. PubMed ID: 15951287
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic methods in the diagnosis of hematologic neoplasms.
Sen F; Vega F; Medeiros LJ
Semin Diagn Pathol; 2002 May; 19(2):72-93. PubMed ID: 12036283
[TBL] [Abstract][Full Text] [Related]
11. [Molecular diagnosis and new gene engineering in hematological malignancies].
Funato T; Fujiwara J; Fujimaki S; Kaku M
Rinsho Byori; 2000 Oct; 48(10):887-91. PubMed ID: 11215098
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of del(20q) in patients with hematological malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
[TBL] [Abstract][Full Text] [Related]
13. Breakpoint differentiation in chromosomal aberrations of hematological malignancies: Identification of 33 previously unrecorded breakpoints.
Heller A; Loncarevic IF; Glaser M; Gebhart E; Trautmann U; Claussen U; Liehr T
Int J Oncol; 2004 Jan; 24(1):127-36. PubMed ID: 14654949
[TBL] [Abstract][Full Text] [Related]
14. FISH panels for hematologic malignancies.
Sreekantaiah C
Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
[TBL] [Abstract][Full Text] [Related]
15. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
Wang HP; Li GX; Qiao ZH; Wang HW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
[TBL] [Abstract][Full Text] [Related]
16. [Essentials of conventional and molecular cytogenetics: application to diagnosis of hematological malignancies].
Lafage-Pochitaloff M
Pathol Biol (Paris); 2003 Aug; 51(6):307-11. PubMed ID: 12927887
[No Abstract] [Full Text] [Related]
17. Incidence of submicroscopic deletions vary according to disease entities and chromosomal translocations in hematologic malignancies: investigation by fluorescence in situ hybridization.
Moon HW; Chang YH; Kim TY; Oh BR; Min HC; Kim BK; Ahn HS; Cho HI; Lee DS
Cancer Genet Cytogenet; 2007 Jun; 175(2):166-8. PubMed ID: 17556074
[TBL] [Abstract][Full Text] [Related]
18. [Application of new FISH techniques for cytogenetic analysis in hematological malignancies].
Kakazu N; Abe T
Rinsho Ketsueki; 2002 May; 43(5):316-8. PubMed ID: 12096476
[No Abstract] [Full Text] [Related]
19. [Minimal residual disease in hematology].
Rák K
Orv Hetil; 2001 May; 142(21):1091-5. PubMed ID: 11449837
[No Abstract] [Full Text] [Related]
20. [In situ hybridization techniques. Basis and applications in hematologic neoplasias].
Espinet B; Lloveras E; Solé F
Sangre (Barc); 1999 Aug; 44(4):261-7. PubMed ID: 10589277
[No Abstract] [Full Text] [Related]
[Next] [New Search]
